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INTRODUCTION                                                                
There is a strong link between chronic kidney disease (CKD) and 
cardiovascular disease (CVD). They share common risk factors such as 
smoking, hypertension, diabetes, obesity and hyperlipidaemia, which are 
important causes of death in both developing and developed countries. 
Developing and implementing programmes for 
early detection, management and prevention 
of kidney and cardiovascular disease
Patients with a reduced GFR are particularly prone to CVD,(1) and 
more likely to die of CVD before entering a dialysis or transplant 
programme. 
To make matters worse, the burden of CVD is increasing.(2) CVD 
contributed 30% of all deaths in the world in 1998, most (78%) 
occurring in low and middle-income countries.(3) The global burdens of 
diabetes and CVD are set to rise by around 50% and 150% in the 
developed and the developing worlds respectively. It is estimated that 
by 2020, in Africa alone, nearly 22.3 million people will be affected with 
diabetes, resulting in concomitant increases in the prevalence of chronic 
kidney disease (CKD) and end-stage renal disease (ESRD).(4) This means 
that more patients will die of strokes, heart failure and kidney failure, 
with the impact greatest in the developing countries like South Africa.
In under-resourced health systems, the focus has to move from 
expensive “end of the road” interventions such as dialysis, trans-
plantation, cardiac catheterization and stenting to early intervention 
and primary prevention strategies by integrating care between 
specialists, primary care clinicians and the community. As CVD and 
CKD share similar risk factors, common preventative strategies may 
result in benefi t for both. For instance, in Australia CKD requiring dialysis 
is almost epidemic among Australian Aboriginal people, and the 
Australian integrated Chronic Disease Outreach Programme (CDOP)(5) 
was instituted to reduce the number of Aboriginal Australians starting 
dialysis in the Northern Territory. It was an integrative approach, which 
focused on detecting and treating common risk factors for CKD, namely 
hypertension, diabetes, and/or proteinuria. The programme substantially 
reduced the number of people needing dialysis and the all-cause 
mortality (Figure 1). The latter was due predominantly to a reduction in 
CVD such as heart failure and stroke. In chronic illness treatment 
programmes most affected people have more than one morbidity, 
justifying integrated, rather than disease specifi c programmes.(6) It was 
uncommon in the Australian CDOP for a patient to have a single risk 
factor, i.e. CKD, hypertension or diabetes alone.
Unfortunately, as well as a large burden of non-communicable diseases 
(hypertension, diabetes) in developing countries, there is the additional 
problem of infectious diseases impacting on the increased prevalence 
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Chronic Kidney Disease (CKD) and Cardio-
vascular Disease (CVD) appear to be closely linked but also share 
common risk factors, making prevention, early detection and 
management for both diseases similar. 
In 1998 CVD accounted for 30% of deaths worldwide and in South 
Africa for almost 40% in the same year. The number of these deaths 
due to underlying CKD remains unanswered, but it is clear that early 
detection and management of CKD through screening of patients at 
high risk, e.g. those with uncontrolled hypertension, diabetes and 
proteinuria or proteinuria alone, is an appropriate way to control 
this massive chronic disease burden. Added to this equation is the 
impact of HIV and/or proteinuria as a cause of CKD and CVD. 
Against a backdrop of poor control and management of chronic 
illnesses, there is a growing number of clinicians attempting to tackle 
this problem through the development of CVD and CKD prevention 
and early detection programmes.
Recognising the common risk factors makes it easier to plan and 
implement such programmes. 
This article looks at an “Integrated Model” for managing chronic 
illnesses, which has been adopted internationally and locally. It 
discusses the experiences and challenges faced in attempting to 
implement programmes for CVD and CKD.
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of both CVD and CKD. HIV is obviously a special example of such an 
infectious disease whose impact has been greatly felt in both.
There is little information on HIV and CVD and CKD to inform planning 
of systematic chronic disease management programmes in the South 
African setting.
Non-communicable diseases (NCD) account for 37% of all deaths in 
SA and HIV for a further 30% (Figure 2).(7) The HIV/AIDS epidemic 
continues to grow at a rapid rate. The UNAIDS estimates that in 2000, 
19.9 % of adults were infected. Projections differ somewhat, but suggest 
that between 2000 and 2010, somewhere between 4-7 million people 
will die of AIDS.(8) The estimated burden of renal deaths in HIV is 
unknown. HIV, when treated with anti-retroviral agents, can behave like 
a chronic disease. The combined impact of diseases like diabetes, 
hypertension and HIV will have a large impact on both CKD and CVD. 
The KDOQI guidelines have signifi cantly improved our focus for 
detecting, following and managing patients with CKD.(9) No reliable 
statistics for CKD exist for any African countries, including SA. In a 
chronic disease outreach programme (CDOP) running in Soweto, it 
was found amongst 619 patients being managed at primary care clinics 
with high risk diabetes (diabetes with hypertension or proteinuria) and 
uncontrolled hypertension that 9% (54) had advanced kidney disease, 
i.e. GFR <60mls/min or signifi cant proteinuria and some 4 patients (2%) 
required immediate dialysis (Table 1).(10) Considering that only a small 
number of the 40 000 patients being treated at these clinics were 
screened, the problem is larger than we would like to think. 
FIGURE 1: Dialysis Starts and Natural Deaths in Adults (18+ yr) being managed on Australian integrated Chronic Disease Outreach Program#
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FIGURE 2: Cause of death proﬁ le in South Africa from the SA Demographic Survey 
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TABLE 1: Reasons for referral to a specialist from primary care level chronic 
disease outreach programme
No graduation 526 85
Stage3/4 CKD# 43 7
Stage 5 CKD # 4 1
Cardiac 7 1
Proteinuria 7 1
DM insulin 7 1
Cholesterol* 19 3
Died 4 1
Graduation PercentTotal(n)
# CKD=chronic kidney disease * Cholesterol = >7mmol/l
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RECOGNISING COMMON RISK FACTORS FOR       
PLANNING OF PREVENTION STRATEGIES
We need to understand and grasp the burden of risk factors on chronic 
diseases in South Africa so that we can further recognize the need for 
a comprehensive early detection and prevention strategy.
The CVD burden and therefore, given the shared risk factor profi le, the 
CKD burden in SA was evaluated to some extent in the South Africa 
Demographic and Health Survey (SADHS) in 1998. This national cross-
sectional survey is probably the most geographically representative 
survey to date.(11) A random sample of 13 802 people, evaluated the 
prevalence and treatment status of hypertension in South Africans ≥15 
years old. The cut-off blood pressure levels used for analysis were 
≥160/95mmHg but later analysis by Steyn included the more appropriate 
cut-off of >140/90.(7) The prevalence of hypertension was found to be 
21% in both men and women, but the level of control was found to be 
worse in men compared with women (10% and 18%), and worse than 
the control in the NHANES III survey of 27%. Just over 50% were 
aware of their diagnosis and less than 50% were being treated. Thus, 
hypertension remains poorly diagnosed and managed in SA. In an 
unpublished review of chronic disease control in Soweto clinics, the 
control of hypertension and diabetes was dismal.(12) Only 8.4% of 
patients seen at the clinics had moderately acceptably control of blood 
pressure (<140/90mmHg) and this was similar for diabetes control 
(<7% having blood glucose < 8mmol/L). 
Diabetes mellitus is also a major problem and is conservatively estimated 
to occur in 4 million South Africans.(11) Diabetic nephropathy remains a 
very important risk factor for CKD and CVD in SA. Incipient 
nephropathy is reported in 32% to 57% with a mean known duration 
of diabetes of 5-10 years in a hospital based study.(13) Overt proteinuria 
was reported in 5% to 28% and increased with duration of diabetes. 
SADHS indicated that a further 4 million South Africans are suspected 
to have a further CVD and CKD risk, that of hyperlipidaemia.
SADHS also showed that 29% of females and 9% of males were obese 
(BMI > 30kg/m2), and 55% and 29% respectively were overweight 
(BMI >25kg/m2). In the Pilot Soweto chronic disease outreach 
programme, the presence of major risk factors was extremely 
prominent (Table 2) and over 60% were obese by BMI and 43% by 
waist-hip ratios.(11) In the same population group 35% had evidence of 
proteinuria. In a recent survey of 551 people in the “normal population” 
in Soweto as part of the “Heart Awareness Day” programme, similar 
risk factor profi les were observed; 43% with a body mass index 
>30 kg/m 2, 8% diabetes, 5% cholesterol >5.5mol/L, 29% 1+ or 
more microalbuminuria on single testing, 16% smokers and 26% with 
hypertension. It was also noted as many as 8% of people screened 
were unaware of their hypertension status (Figure 3).(14)
These studies highlight the existence of co-existing risk factors and co-
morbidities in chronic disease and “normal” populations. It also 
demonstrates the poor awareness and management of these risk 
factors and chronic diseases in those diagnosed with a problem, making 
TABLE 2: Baseline risk factor profi le of patients screened on the pilot chronic 
disease outreach programme in Soweto; 200-2001(24)
Age * 625 57.5 (11.9)
Male 645 201 (31.2%)
Diabetics * 645 234 (36.3%)
Hypertensive * 645 622 (96.4%)
Smokers * 577 86 (14.9%)
Alcohol 569 98 (17.2)
Waist, cm 583 97.5 (18.8)
BMI, kg/m2 * 581 32.7 (8.6)
Obese by WHR 583 256 (43.9%)
SBP * 619 153.0 (21.6)
DBP 619 93.6 (12.5)
MAP 619 113.4 (14.1)
Parameters
#N
# Data are Mean (SD) or proportions
Patients screened
FIGURE 3: Patients Screened in “Heart Awareness Day” in Soweto
Known HT = people screened who were aware of their diagnosis or were being 
treated already for HT
New HT = people unaware of their having hypertension at time of screening
Normal = people screened who had a blood pressure <140/90mmHg
10%
37%
64%
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the argument for early detection of kidney and cardiovascular disease. 
The question remains how we should tackle this problem of CKD and 
CVD.
EARLY DETECTION & PREVENTION: AN                 
INTEGRATED APPROACH
A simple and integrated approach to risk factor and chronic disease 
management needs to be adopted. Lifestyle measures remain the key 
to the epidemic of NCD and HIV in the developing world. Public 
education and commitment to a healthy lifestyle, e.g. stop smoking, low 
salt diets, prudent eating plans, exercise and reducing high risk sexual 
behaviour, need to be emphasized. 
The WHO recognizes the diffi culty in achieving ideal circumstances and 
therefore advises those in the developing world to follow a more practical 
approach. The approach is modifi ed according to one’s capacity. (15) 
A Chronic Disease Outreach Programme (CDOP) was initiated in 1999, 
in Soweto, a city of predominantly indigenous South African people. It is 
a melting pot of “transitional” people, moving from a traditional lifestyle 
to a predominantly unhealthy Westernized urban lifestyle. This community 
is also at high risk for chronic diseases, including HIV.(16) Against a known 
background of poor blood pressure and glucose control, the programme 
was implemented in 20 primary care clinics in Soweto and nearby 
regional clinics. The programme is developed around the Wagner 
Chronic Illness Care Model, which focuses on creating a prepared and 
proactive health team and an informed patient.(17)
This programme is based on an understanding that adequate blood 
pressure control, diabetic control and risk factor control will confer a 
specifi c effect (advantage) in preventing, reversing or retarding diabetes, 
hypertension and proteinuria, as well as those with established CKD 
and CVD.(16) It also recognised the need for community support and 
integrating prevention strategies into the community through, for 
example, support groups for diabetic patients.
It focused on the key components of disease and treated, tracking and 
analyzing clinical outcomes. It also had a qualitative component, which 
served to assess the health delivery system, including health workers 
and patient compliance and satisfaction. In a recent study Landon et al. 
showed the value of evaluation in such public health initiatives.(18) In this 
study they showed that integrated primary health care centers had 
considerably greater improvement in the composite measures of quality 
for the care of patients with chronic illnesses, asthma and diabetes.The 
focus in developing countries is also on high risk groups, recognizing the 
resource capabilities of these health services. 
PROGRAMME MODELS FOR CKD AND CVD            
DETECTION AND MANAGEMENT
The Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical 
Practice Guidelines for Chronic Kidney Disease draw on the results of 
NHANES III and the 1998 USRDS studies to establish the CKD stages. 
This staging protocol has signifi cantly improved our focus for detecting, 
following and managing CKD.(9) However, what this protocol exposed 
was the hierarchical or pyramid shape to kidney disease. It indicated 
that most CKD patients fall into CKD stages 2 or 3. These are also the 
stages in which people are most likely to present with cardiovascular 
morbidity or mortality. So the options when establishing a prevention 
programme are to either screen an entire population, as in the Dutch 
PREVEND programme and the Australian Aboriginal CDOP studies or 
detect a cohort of people at the highest risk of disease (Figure 4).(19, 20) 
The approach in SA and other countries, like Australia, has been to 
focus more on the high risk population groups.(21, 22)
We have a few options to consider before starting a programme. Firstly 
a prevention programme could be established on its own, with the 
FIGURE 4: Potential approaches for early screening for detection and prevention of CKD 
and CVD and risk factors
Whole population
Screening of entire population 
looking for at risk population, 
e.g. South Africa
Selected screening 
of entire smaller 
Community, 
e.g. all people in 
Soweto
Screening of high risk groups in 
primary care and specialist clinics, 
e.g. clinic population of uncontrolled 
hypertensive or diabetic patients 
with proteinuria and/or 
hypertension or 
proteinuria alone 
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primary focus being the kidney or the heart as the organ to treat. The 
second option could be for the kidney or heart to fall under the gambit 
of all chronic illnesses, recognizing that managing the key chronic 
illnesses risk factors such as hypertension and diabetes will have the 
greatest impact on reducing the progression of kidney disease and 
cardiovascular disease.(23) The broad range of kidney and heart problems 
and their etiologies makes the cardiologist or nephrologist well suited 
to follow an integrated approach to these chronic illnesses.(24) 
INTERNATIONAL MODELS FOR CVD AND CKD 
PREVENTION OR EARLY DETECTION
Wendy Hoy’s team state the programme in Australia is probably the 
most experienced in establishing kidney and cardiovascular protection 
programmes. They have helped develop programmes in Australian 
Aboriginal communities as well as other countries including India, Nigeria 
and South Africa. Key to this development is to engage community 
interest in chronic illness management and prevention strategies, to help 
assess needs in the community and to develop an agreement with the 
local community or health authority.(6) Once these basic requirements 
have been met, then one can go on to help local staff implement the 
programme, and strive to ensure sustainability by providing the 
mechanisms or skills to evaluate processes and outcomes. 
Other prevention CKD or CVD programmes or research programmes 
have also been established. An example of such an initiative is 
The Initiative for Cardiovascular Health Research in developing Countries 
(IC Health), an NGO that shares similar interests with the renal 
specialists. Their work is close to the coal face and they have funding 
from the World Bank and other partners, whose aims are to prioritize 
resource-sensitive research and to address the growing burden of 
cardiovascular diseases in the developing countries. They also prioritize 
research on sustainable models of disease prevention through primary 
health care in resource-poor settings. These model programmes deliver 
established safe and effective methods to reliably and affordably prevent 
cardiovascular disease. They acknowledge that, even though these 
methods of prevention are known, e.g. ACE inhibitors, management of 
risk factors, they still need to be delivered. They are therefore trying 
to develop large-scale cost-effective programmes in low and middle-
income countries. The programmes have surveillance and intervention 
components.(25) Other NGOs worldwide are also involved in similar 
prevention strategies, including Médecins Sans Frontières (MSF) and 
Global Forum for Health Research (GFHR).(26, 27)
SOUTH AFRICAN INTEGRATED HEALTH CARE     
MODEL AND STRUCTURE
In the CDOP programme described earlier, a tertiary hospital (Chris 
Hani Baragwanath) served as the focal point for decision support for 
primary care clinicians (PHCs), data collection (surveillance), data 
analysis and overall management of the programme (Figure 5). The 
CDOP “Functioning Unit” was established to fi t into the cluster of 
primary, secondary and tertiary hospitals in a region. This model is the 
basis for public health primary care and tertiary models. It is also a 
model suitable for private health care. It recognizes that a single 
academic or tertiary hospital takes referrals from a region of health 
services, including primary health clinicians (family practitioners) and 
smaller hospitals, e.g. regional hospitals. The key component of this 
model is fi rstly recognizing which patients’ diseases can be managed by 
a primary care centre, which just need advice (decision support) and 
which need referral (specialist management). In developing this model 
it is critical to understand what the PHCs and the existing resources 
can cope with, and when they should refer patients for specialised care. 
The “red”, “orange” and “green” traffi c light approach was used to open 
or keep doors closed for referral. The programme defi ned red to mean 
that the door for referral was opened, e.g. GFR <60mls/min and 
multiple risk factors. An orange “light” was used to indicate the health 
worker should continue with caution and should observe the clinical 
problem until a further review in 6-12 months, e.g. HbA1c not at target 
<7%. A specialist still provided regular decision support if required. 
When a green light was given, then the primary care clinician was 
permitted to continue with management and would screen again at a 
later date. 
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 FIGURE 5: An example of an early detection and prevention programme structure, 
using the Soweto CDOP structure as an example
Primary Care
Facility
Primary Care Facilities referring 
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All centres are linked through CDOP, which acts as the clinical data Information 
capture centre.
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This restructuring of the health system, as per the Wagner Model, 
allowed patients to be referred directly to a specialist clinic without 
being referred through a “casualty” (Figure 6). Patients would then arrive 
at the specialist centre with the appropriate investigations completed 
and a history of the patient’s disease and progress already known. This 
resulted in improved effi ciency in the management of the patient at the 
time of consultation. Once the patient was stabilized, they could be 
referred back to their primary clinic for ongoing care, unless disease was 
too advanced, e.g. GFR >30mls/min. Such a patient would remain at the 
tertiary centres kidney disease remission and regression clinic and be 
prepared for dialysis or transplantation if necessary at a later stage.
Such initiatives could easily be adapted for the private health care 
sector.
CHALLENGES WHEN ESTABLISHING DETECTION 
PROGRAMMES
It is defi nitely possible to establish a chronic disease outreach programme 
in the developing world. There are some additional important 
fundamental issues to consider and remember when developing and 
implementing programmes for preventing kidney and cardiovascular 
disease. It is important to develop strong links with experts and to try 
and develop assistance when needed from local or international 
organizations that have had experience in prevention and early 
detection programmes. One has to ensure that, when managing chronic 
diseases in less developed countries, the establishment of an informed 
and proactive health team and strong patient and community 
partnerships are a priority. Establishing links and improved communi-
cation between primary, secondary and tertiary services takes ongoing 
joint planning and commitment. These components remain as important 
as adequate funding, although funding is an essential component. One 
has to focus not only on the technical aspects, but also on supporting and 
caring for staff. It is critical to recognise that good quality chronic disease 
management is best care delivered by a well functioning team, and does 
not rest on only the specialist or primary care clinician alone.(25) 
The fundamental diffi culties outlined in most prevention programmes 
are the staff shortages of local health workers and frequent absenteeism 
and attrition in clinics. These issues impact on health care more broadly. 
The causes are complex and deep-seated, but improved incentives for 
health workers, proper pay scales, empowerment, respect and good 
backup are all needed. High drop-out rates, up to 62% in both phases 
of the South African programme have occurred due to: 1) staffi ng 
shortages; 2) inability of the nurses to fi ll in follow-up data when 
patients return; and 3) cutting of costs by the local regional health 
service. Continuity of care is a major problem in SA, with clinics seeing 
volumes of 3 000-5 000 chronic disease patients per month and patient 
nurse ratios of 1:50 or 60.(28) There are only two Nurse Coordinators 
following up patients in our CODP. Follow-up was thus dependent on 
local clinic support. All primary health care nurses were reluctant to 
be involved and nurses involved were not always available due to days 
off and having to rotate to other areas of the clinic (i.e. acute patient 
care, ARV programmes). 
Ongoing challenges in SA include the lack of coordinator personnel at 
each site to facilitate the running and day-to-day management of the 
programme and especially the lack of insight and support from some 
senior department of health managers. Prevention strategies do not 
bring in immediate savings and cost effi ciency, making prevention strategies 
less attractive. Early detection and good quality care may in fact result in 
an increase in initial cost for health care. The communication linkages 
include improved access to doctors at the tertiary/specialist care facility. 
Demands on time, compounded with the public health care system 
culture, remained a barrier to the programme’s success in Soweto.
Despite shortages of staff and problems with running the programmes, 
the improvements in risk reduction, if sustained, should result in 
reduction in morbidity and mortality. This was glaringly obvious in the 
 FIGURE 6: CDOP Model used for screening, early detection and referral of patients 
with advanced chronic kidney disease, or uncontrollable cardiovascular risk factors
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There is a raised awareness for an integrated approach to management 
of chronic conditions. The WHO and initially Wagner have popularized 
similar models(24, 29) of integrated care. These models capture the 
complexity of providing health care for chronic conditions in an 
organized way.(24, 28)
CONCLUSIONS - INTEGRATED APPROACH TO CKD 
MANAGEMENT
Novel methods of tackling the increased burden of CKD and CVD 
have to be established in the developing world if we are to tackle the 
daunting future burden facing our communities. We have to move from 
the “fi nd and fi x it” model of treating diseases to a more proactive 
integrated approach of tackling common risk factors, early detection of 
high risk patients, and then joint specialist and primary health care 
management. Health Care Funders (government and private medical 
aids) have to recognise the importance of prevention, early detection 
and comprehensive integrated strategies to managing CKD and CVD, 
and also have to be prepared to fund such initiatives. In treating the 
common diseases and risk factors like diabetes, hypertension, obesity, 
hyperlipidaemia and HIV, we will ultimately be reducing the burden and 
morbidity of CKD and CVD in our communities. The examples and 
lessons learned in SA and in other countries where prevention 
programmes have been established could serve as a template as well as 
a stepping stone for other developing world and African communities. 
